Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure
暂无分享,去创建一个
Kengo Ito | Gen Sobue | Masaaki Hirayama | Yutaka Arahata | Takashi Kato | Takashi Kato | Kengo Ito | G. Sobue | Y. Koike | M. Tadokoro | Y. Arahata | M. Hirayama | Toshiaki Ieda | Yasuo Koike | Masanori Tadokoro | Mitsuru Ikeda | T. Ieda | Mitsuru Ikeda
[1] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[2] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[3] Michael E. Phelps,et al. Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] R A Margolin,et al. Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. , 1983, Brain : a journal of neurology.
[5] D. Benson,et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. , 1983, Archives of neurology.
[6] K Kosaka,et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.
[7] R A Koeppe,et al. Alternative Approach to Single-Scan Estimation of Cerebral Glucose Metabolic Rate Using Glucose Analogs, with Particular Application to Ischemia , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] D Comar,et al. Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[9] C. Markham,et al. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease , 1984, Annals of neurology.
[10] N. Quinn,et al. Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[11] L. Wolfson,et al. Antemortem diagnosis of diffuse Lewy body disease , 1990, Neurology.
[12] S. Kato,et al. Development of the revised version of Hasegawa's Dementia Scale (HDS-R) , 1991 .
[13] G. Fink,et al. Positron emission tomography in the differential diagnosis of organic dementias. , 1991, Journal of neural transmission. Supplementum.
[14] J R Moeller,et al. Effects of Percent Thresholding on the Extraction of [18F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Masayuki Sasaki,et al. Regional cerebral glucose metabolism in patients with Parkinson’s disease with or without dementia , 1992, Annals of nuclear medicine.
[16] M Schulzer,et al. Cerebral glucose metabolism in Parkinson's disease with and without dementia. , 1992, Archives of neurology.
[17] Christopher J. Mathias,et al. Investigation of autonomic disorders , 1992 .
[18] S. Kuzuhara,et al. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. , 1993, Advances in neurology.
[19] A. Lees,et al. A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.
[20] J D Brodie,et al. Intersubject variability of brain glucose metabolic measurements in young normal males. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] William J. Jagust,et al. Cortical glucose metabolism in Parkinson's disease without dementia , 1994, Neurobiology of Aging.
[22] A. Alavi,et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] T. Momose,et al. Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy , 1995, Journal of the Neurological Sciences.
[24] R. Albin,et al. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease , 1996, Neurology.
[25] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[26] G. Alexander,et al. The Metabolic Topography of Normal Aging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[28] N. P. Quinn,et al. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy , 1996, Neurology.
[29] Mathias Cj. Disorders affecting autonomic function in parkinsonian patients. , 1996 .
[30] Y. Koike,et al. Autonomic dysfunction in Parkinson's disease. , 1997, European neurology.